LONDON--(Marketwire - April 24, 2008) - Curidium Medica plc (LSE: CUR) ("Curidium" or the "Company"), the personalized medicine company focused on bringing the right drug to the right patient, today announced that Dave Michalovich, Ph.D., Head of Drug Target Research, will be presenting at the Ingenuity Systems European User Group Meeting in France on 25 April at 1:15pm local time at Sofitel Le Mediterranee, Cannes, France.
